These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4143918)

  • 21. Pharmacological characterisation of -receptor blocking agents.
    Saameli K
    Jpn J Pharmacol; 1972; 22():Suppl22:13. PubMed ID: 4403917
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the effects of nine beta-adrenergic blocking agents on intraocular pressure in rabbits.
    Bonomi L; Perfetti S; Noya E; Bellucci R; Massa F
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Mar; 210(1):1-8. PubMed ID: 35031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of chronotropic and inotropic effects of different beta adrenolytic drugs].
    Cheymol G; Mouillé P; Laubie M; Schmitt H
    C R Seances Soc Biol Fil; 1972; 166(6):823-8. PubMed ID: 4143908
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol)].
    Adamska-Dyniewska H
    Wiad Lek; 1973 Jul; 26(13):1201-5. PubMed ID: 4147032
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparison of the pA2 of various beta blocking agents].
    Spach MO; Miesch F; Schwartz J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3221-2. PubMed ID: 3766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of several -adrenoceptor blocking drugs in the pregnant sheep and foetus.
    Truelove JF; van Petten GR; Willes RF
    Br J Pharmacol; 1973 Jan; 47(1):161-71. PubMed ID: 4146153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duration of action of beta-blocking drugs.
    Carruthers SG; Kelly JG; McDevitt DG; Shanks RG; Walsh MJ
    Br Med J; 1973 Apr; 2(5859):177. PubMed ID: 4144672
    [No Abstract]   [Full Text] [Related]  

  • 31. The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
    Abrahamsson T
    Br J Pharmacol; 1986 Apr; 87(4):657-64. PubMed ID: 2871880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
    Goch JH
    Pol Tyg Lek; 1972 Dec; 27(52):2049-51. PubMed ID: 4405621
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    Singh BN
    N Z Med J; 1973 Dec; 78(505):529-35. PubMed ID: 4150209
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
    Kubota M; Gotho Y; Furukawa K
    Masui; 1979 Aug; 28(8):797-804. PubMed ID: 43404
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effects of coronary actve drugs on membrane metabolism and permeability].
    Pohl A; Moser K
    Arzneimittelforschung; 1972 Dec; 22(12):2049-53. PubMed ID: 4145349
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 38. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of the rat renal Na+/H+ exchanger by beta-adrenergic antagonists.
    Friedrich T; Burckhardt G
    Biochem Biophys Res Commun; 1991 Feb; 175(1):311-7. PubMed ID: 1671814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.